Authors:
Annicotte, JS
Schoonjans, K
Haby, C
Auwerx, J
Citation: Js. Annicotte et al., An E-box in pGL3 reporter vectors precludes their use for the study of sterol regulatory element-binding proteins, BIOTECHNIQU, 31(5), 2001, pp. 993
Authors:
Desreumaux, P
Dubuquoy, L
Nutten, S
Peuchmaur, M
Englaro, W
Schoonjans, K
Derijard, B
Desvergne, B
Wahli, W
Chambon, P
Leibowitz, MD
Colombel, JF
Auwerx, J
Citation: P. Desreumaux et al., Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (BPAR gamma) heterodimer: A basis for new therapeutic strategies, J EXP MED, 193(7), 2001, pp. 827-838
Authors:
Tarrade, A
Schoonjans, K
Guibourdenche, J
Bidart, JM
Vidaud, M
Auwerx, J
Rochette-Egly, C
Evain-Brion, D
Citation: A. Tarrade et al., PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation, ENDOCRINOL, 142(10), 2001, pp. 4504-4514
Authors:
Schoonjans, K
Gelman, L
Haby, C
Briggs, M
Auwerx, J
Citation: K. Schoonjans et al., Induction of LPL gene expression by sterols is mediated by a sterol regulatory element and is independent of the presence of multiple E boxes, J MOL BIOL, 304(3), 2000, pp. 323-334
Authors:
Dubois, M
Pattou, F
Kerr-Conte, J
Gmyr, V
Vandewalle, B
Desreumaux, P
Auwerx, J
Schoonjans, K
Lefebvre, J
Citation: M. Dubois et al., Expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) in normal human pancreatic islet cells, DIABETOLOG, 43(9), 2000, pp. 1165-1169
Authors:
Fajas, L
Schoonjans, K
Gelman, L
Kim, JB
Najib, J
Martin, G
Fruchart, JC
Briggs, M
Spiegelman, BM
Auwerx, J
Citation: L. Fajas et al., Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1. Implications for adipocyte differentiation and metabolism, MOL CELL B, 19(8), 1999, pp. 5495-5503
Authors:
Schoonjans, K
Peinado-Onsurbe, J
Fruchart, JC
Tailleux, A
Fievet, C
Auwerx, J
Citation: K. Schoonjans et al., 3-hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase, FEBS LETTER, 452(3), 1999, pp. 160-164